Compare Quest Diagnostics Inc (DGX) vs Vanguard Total World Stock Index Fund ETF (VT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Vanguard Total World Stock Index Fund ETF — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Vanguard Total World Stock Index Fund ETF trades at $161.6. The key difference: Quest Diagnostics Inc pays a 1.45% dividend while Vanguard Total World Stock Index Fund ETF pays none. Which is the better fit depends on your goals.
| DGX | VT | |
|---|---|---|
Market Cap | $26.21B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $238.50 | $161.30 |
52-Week Low | $173.49 | $132.19 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Vanguard Total World Stock Index Fund ETF
VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →
